The American Journal of Medicine
Volume 110, Issue 5 , Pages 352-360, 1 April 2001

Efficacy and safety of combination simvastatin and colesevelam in patients with primary hypercholesterolemia☆

  • Howard H Knapp, MD, PhD

      Affiliations

    • Lipid Research Clinic (HHK, HS), University of Iowa, Iowa City, Iowa, USA
    • ,
  • Helmut Schrott, MD

      Affiliations

    • Lipid Research Clinic (HHK, HS), University of Iowa, Iowa City, Iowa, USA
    • ,
  • Patrick Ma, MD

      Affiliations

    • Bridgeland Medical (PM), Calgary, Alberta, Canada
    • ,
  • Robert Knopp, MD

      Affiliations

    • Northwest Lipid Research Center (RK), Seattle, Washington, USA
    • ,
  • Bruce Chin, MD

      Affiliations

    • Long Island Jewish Medical Center (BC), Manhasset, New York, New York, USA
    • ,
  • J.Michael Gaziano, MD

      Affiliations

    • VA Boston Healthcare System and Brigham and Women’s Hospital (JMG), Boston, Massachusetts, USA
    • ,
  • Joanne M Donovan, MD, PhD

      Affiliations

    • GelTex Pharmaceuticals, Inc. (JMD, SKB), Waltham, Massachusetts, USA
    • Corresponding Author InformationRequests for reprints should be addressed to Joanne M. Donovan, MD, PhD, GelTex Pharmaceuticals, Inc., 153 Second Avenue, Waltham, Massachusetts 02451
    • ,
  • Steven K Burke, MD

      Affiliations

    • GelTex Pharmaceuticals, Inc. (JMD, SKB), Waltham, Massachusetts, USA
    • ,
  • Michael H Davidson, MD

      Affiliations

    • Chicago Center for Clinical Research (MHD), Chicago, Illinois, USA

Received 17 August 2000; received in revised form 11 December 2000; accepted 11 December 2000.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

☆ Funded by GelTex Pharmaceuticals, Inc., Waltham, Massachusetts.

PII: S0002-9343(01)00638-6

The American Journal of Medicine
Volume 110, Issue 5 , Pages 352-360, 1 April 2001

Article Tools

* Image Usage & Resolution